Skip navigation menu

American Health Security Act

Health Policy Priorities: New York's 12th Congressional District 
What I will introduce, fund, and fight for in Congress 

1. Affordable Health Care

The evidence: 27 million Americans are uninsured; a number is projected to rise as federal rollbacks accelerate. Nearly 1 in 4 working-age adults are underinsured — with cost-sharing so high that 57% skip or delay necessary care (Commonwealth Fund, 2024). In NY-12, 29,300 residents depend on enhanced ACA tax credits; if those expire, premiums rise $80 a month. Every $1 invested in Medicaid generates an estimated $1.50-$2.00 in economic activity (Medicaid and CHIP Payment and Access Commission). CBO estimated in 2019 that a Medicare buy-in option at age 60 would cover approximately 4-5 million additional Americans. 

Protecting existing coverage is necessary but not sufficient. I will make permanent the enhanced ACA subsidies and defend Medicaid from block grants, per-capita caps, and work requirements. I will add dental, vision, and hearing to Medicare, expand the Medicare Savings Program by raising income thresholds and eliminating asset tests, and defend New York's Section 1115 Medicaid waiver, which authorizes $3 billion for housing, nutrition, and transportation as health interventions. These protections safeguard coverage millions of New Yorkers depend on today. The structural path to universal coverage is progressive Medicare expansion. I will introduce legislation to lower the eligibility age from 65 to 60 as a first step toward 55 and ultimately a system that covers everyone. Lowering to age 60 creates a coverage option for people who retire early or lose employer coverage — and removes older, higher-cost enrollees from the ACA risk pool, reducing premiums for younger families. Each step toward a lower eligibility age builds the political and fiscal case for further expansion. 

2. Cheaper Drugs

The evidence: A 2021 RAND Corporation study found U.S. drug prices average 2.56 times higher than in 32 comparable countries on a net basis — higher for branded drugs. One in three Americans report skipping doses or not filling prescriptions because of cost (KFF, 2023). The IRA's Medicare negotiation authority is projected by CBO to save $98.5 billion over ten years — but prices don't take effect until 2026, and recent legislation has already eroded an estimated 10% of those savings. Extending negotiated prices to Medicaid and private insurers would generate an estimated additional $500 billion in savings over a decade. 

The federal government invests roughly $50 billion annually in NIH and other biomedical research. Public funding contributed to every one of the 210 drugs approved by the FDA between 2010 and 2016. Despite this, U.S. drug prices bear no statutory relationship to the public investment behind them. I will expand the IRA: shorten exclusivity periods before negotiation eligibility from 7/11 years to 3/5 years, consistent with international norms; remove the cap that currently limits negotiation to the top 50 drugs by Medicare spending, bringing hundreds of additional drugs into scope; and extend negotiated prices as a binding ceiling for Medicaid and private insurers, with direct benefit to 3.9 million New Yorkers on Medicare and 7.5 million statewide on Medicaid. I will require enforceable affordable pricing conditions on any federal grant or license for drug development. I will also seek to strengthen march-in rights under the Bayh-Dole Act — rights never successfully exercised in 50 years but recently updated by the Biden administration — so that taxpayer-funded drugs priced out of reach face a credible competitive alternative. And I will mandate full public disclosure of actual R&D costs, separating research expenditure from marketing and stock buybacks. 

3. Primary Care For All

The evidence: Countries with stronger primary care systems have better health outcomes and lower costs (Starfield, Shi & Macinko; OECD). In the U.S., Community Health Center (CHC) patients have lower rates of preventable hospitalization and ER use than comparable patients without a primary care home. Federal funding per CHC patient has fallen from $138 to $107 since 2020 in real terms, and nearly half of all CHCs ran negative margins in 2023. The infrastructure exists and is proven — it is chronically underfunded. 

In NY-12, 30,000-37,000 residents are uninsured, Hispanic residents are nearly three times as likely to lack coverage as White residents, and routine appointments take 2-4 weeks. Nationally, 75 million Americans live in federally designated primary care shortage areas, a shortage associated with higher rates of preventable hospitalizations and avoidable ER use. I will introduce the Free Primary Care for All Act — to support existing CHCs so they can meet patient needs and to expand CHC sites, with strategic placement in underserved communities — including Ryan Health and Housing Works in our district. Specifically, I will legislate to: increase Section 330 grant funding indexed to inflation; raise Medicaid reimbursement rates so HCs can pay competitive salaries, the primary barrier to recruitment and retention; expand the National Health Service Corps and create a National Public Service Corps

combining salary support and loan forgiveness; fund 2,000 additional NP and PA training slots annually; and require states to grant full practice authority to NPs, PAs, and Certified Nurse-Midwives currently blocked by state law. I will also reverse the $8 billion in Medicaid DSH cuts that took effect October 1, 2025 — New York's safety net hospitals received $2.1 billion in DSH funding in FY2022 — with another $16 billion in cuts scheduled. 

Sources: Advocates for Community Health (2024); Commonwealth Fund FQHC Survey (2023); GNYHA DSH analysis; NY State of Health CD-12 Fact Sheet (Jan. 2025); Commonwealth Fund Biennial Health Insurance Survey (2024); CBO IRA scoring; KFF OBBBA analysis; Public Citizen — Taxpayer Funded Drugs (2023); KFF Medicare age-reduction estimate; HRSA/AAMC shortage projections.

We want to hear from you

Get Involved!

Question 1: What is one health care issue you have faced that you feel this policy does not sufficiently address?  

Question 2: Are we being bold enough in our approach to universal coverage? 

Question 3: Beyond costs and coverage, what are practical barriers that we need to address to make care truly accessible in NY-12?

Question 4: Are there other statutory authorities or funding mechanisms we should be leveraging to achieve these goals?